NPI: 1356396915 · CHARLOTTE, NC 28203 · Pediatrics Physician · NPI assigned 05/23/2006
Authorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
| Authorized Official | WALTON, LEEA (RCS MANAGER) |
| NPI Enumeration Date | 05/23/2006 |
Other providers sharing the same authorized official: WALTON, LEEA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,486 | $92K |
| 2019 | 3,043 | $134K |
| 2020 | 2,944 | $111K |
| 2021 | 15,391 | $321K |
| 2022 | 27,849 | $380K |
| 2023 | 19,241 | $208K |
| 2024 | 14,435 | $39K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5,861 | 4,534 | $356K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,631 | 2,299 | $239K |
| 99199 | Unlisted special service, procedure or report | 56,163 | 54,628 | $186K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3,434 | 2,944 | $165K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1,125 | 976 | $102K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 591 | 516 | $59K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,292 | 924 | $59K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,445 | 1,005 | $23K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2,419 | 2,067 | $23K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,114 | 1,063 | $21K |
| 96127 | 3,696 | 3,158 | $16K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 332 | 323 | $11K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 71 | 64 | $7K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 51 | 41 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 58 | 43 | $4K |
| D0145 | Oral evaluation for a patient under three years of age | 83 | 77 | $3K |
| 90461 | 1,014 | 895 | $2K | |
| D1206 | Topical application of fluoride varnish | 83 | 77 | $1K |
| 90686 | 1,169 | 1,070 | $980.06 | |
| 90474 | 28 | 27 | $490.80 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 15 | 14 | $462.02 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 32 | 15 | $357.45 |
| 92552 | 244 | 202 | $354.64 | |
| 85018 | 290 | 252 | $137.75 | |
| 92551 | 496 | 448 | $122.68 | |
| 99173 | 540 | 485 | $70.09 | |
| 96161 | 13 | 13 | $51.09 | |
| 99177 | 160 | 131 | $18.62 | |
| 90670 | 421 | 383 | $0.00 | |
| 90648 | 28 | 26 | $0.00 | |
| 90698 | 290 | 274 | $0.00 | |
| 90674 | 73 | 59 | $0.00 | |
| 90744 | 27 | 27 | $0.00 | |
| 90680 | 86 | 81 | $0.00 | |
| 36416 | 14 | 14 | $0.00 |